Education
About Us
Working with TipRanks
Follow Us
Nuvectis Pharma (NVCT)
NASDAQ:NVCT
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Operating Income | $ -27.57M | $ -19.85M | $ -22.90M | $ -19.23M | $ -12.89M |
| EBITDA | $ -27.57M | $ -19.00M | $ -22.90M | $ -19.23M | $ -12.89M |
| Net Income | $ -26.44M | $ -19.00M | $ -22.26M | $ -19.09M | $ -12.89M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 31.63M | $ 18.53M | $ 19.13M | $ 19.99M | $ 5.74M |
| Total Assets | $ 31.71M | $ 18.61M | $ 19.18M | $ 20.41M | $ 6.66M |
| Total Debt | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Net Debt | $ -31.63M | $ -18.53M | $ -19.13M | $ -19.99M | $ -5.74M |
| Total Liabilities | $ 13.30M | $ 8.89M | $ 6.98M | $ 6.19M | $ 17.66M |
| Stockholders' Equity | $ 18.41M | $ 9.71M | $ 12.20M | $ 14.22M | $ -11.01M |
| Cash Flow | |||||
| Free Cash Flow | $ -16.01M | $ -12.25M | $ -15.95M | $ -13.56M | $ -9.50M |
| Operating Cash Flow | $ -16.01M | $ -12.25M | $ -15.95M | $ -13.56M | $ -9.50M |
| Investing Cash Flow | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Financing Cash Flow | $ 29.11M | $ 11.65M | $ 15.09M | $ 27.81M | $ 15.25M |